Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
Daiichi Sankyo Europe GmbH logo

Daiichi Sankyo Europe GmbH

Self-Owned
製薬製造1,300+ employeesFounded 1899🇩🇪 ドイツ
本社
🇩🇪Munich (+1)
業種
製薬製造
従業員数
1,300+
設立年
1899
企業タイプ
Self-Owned
ランキング
#4,168,032

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field. We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company. In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. Imprint: https://www.daiichi-sankyo.eu/imprint/ All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

専門分野
製薬バイオテクノロジー医療製薬製造
12 / 14
アクティブな市場
トルコ · イタリア · スイス
0
新規市場
今期はなし
22
シグナル
過去 90 日間
-62%
モメンタム
前期比
拡大スコア発展中
28 / 100

グローバル展開

ライブ
トルコイタリアスイス
最大 3 市場
過去 90 日間
ステージ
検討中5投入中9展開中0規模拡大中0
最近の動き
進行中30日
新規90日
+11さらに市場ロック中
14件中3件を表示

市場タイムラインとシグナルフィードを解放

アクティビティパルス

過去 90 日間に 22 件のシグナル。

過去 90 日間
採用
12
採用
マーケティング・PR
9↓ 終了
広告
プロダクト・技術
1↓ 終了
クラウドフットプリント
+2さらにカテゴリロック中
5件中3件を表示

市場参入タイムライン

この企業が各市場へ参入した順序 — 古い順から新しい順へ

1
🇹🇷トルコ1st 番目に参入した市場 · 2024
投入中
29 件のシグナル
2
🇨🇭スイス2nd 番目に参入した市場 · 2024
投入中
27 件のシグナル
3
🇮🇹イタリア3rd 番目に参入した市場 · 2025
検討中
28 件のシグナル
+11さらに市場ロック中
14件中3件を表示
現在のステージ投入中リソースを投入中
信頼度39%低
追跡開始2024最初のシグナル

最近のシグナル

採用🇮🇪 アイルランド今日

Brand Manager Oncology

採用🇵🇹 ポルトガル先週

PT-Marketing Manager Oncology

登録してシグナルフィードをすべて表示

知っておきたい情報

Daiichi Sankyo Europe GmbH に関するよくある質問

Daiichi Sankyo Europe GmbH の事業、市場、成長シグナルに関する簡潔な回答。

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field. We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company. In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. Imprint: https://www.daiichi-sankyo.eu/imprint/ All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

800M+
監視企業数
50+
ローカルデータソース
16
企業動向シグナル
毎日
更新頻度
「進出したその週にアカウントへアプローチする——四半期後ではなく。」
グロース責任者 · Pubrio を使う500名超の営業チーム

世界中の企業の動きを、見る。

ムーブメントマップのウォークスルーをチームと一緒に予約しましょう。

pubrio

Pubrio は 200 以上の市場にわたる進出シグナルを一つのライブグラフに束ね、どの企業が新市場に参入しているかをレベニューチームに示し、タイミングを捉えられるようにします。

フォロー

AI に Pubrio について聞く

AIエージェント向け

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio. 無断転載を禁じます。